Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Average Recommendation of “Hold” from Analysts
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given a consensus recommendation of “Hold” by the twelve analysts that are currently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and three have assigned a buy recommendation to […]
27 Dec 02:56 · The Cerbat Gem